Canaan Partners | Activity | F4

Introducing F4 Champions, a new accelerator for founders at the earliest stage.F4 Champions for early-stage foundersEnrollment closesAugust 2Learn more

Team Portfolio Raise Champions Essays

F4/Canaan Partners/Activity

Canaan Partners Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

Essay

Published thesis on B2B agentic payment systems as an emerging opportunity.

B2B Agentic Payments: The Unglamorous Opportunity That Actually Matters

Canaan Partners

Added recently

Exit

Portfolio company Halda Therapeutics acquired by Johnson & Johnson for $3.05B.

Halda Therapeutics

Halda TherapeuticsCanaan Partners

Added recently

Investment

Led OpenArt's $30M Series A round for AI-native visual creativity platform.

OpenArt

OpenArt Canaan Partners

Added recently

Essay

Essay exploring how AI agents are automating core business functions and the importance of early adoption.

Agent Economy: Darwin Is Running Your Next Board Meeting

Canaan Partners

Added recently

Essay

Essay on how AI is collapsing barriers to custom software development for domain experts.

A Message to You, Rudie

Canaan Partners

Added recently

Milestone

Rondo Therapeutics dosed first patient in Phase 1 trial for bispecific antibody RNDO-564.

Rondo Therapeutics

Rondo Therapeutics Canaan Partners

Added recently

Milestone

Hermeus completed first flight of Quarterhorse Mk 2.1 hypersonic aircraft.

Hermeus

Hermeus Canaan Partners

canaan.comAPR 2026

APR 2026

Investment

Led OpenArt's $30M Series A for creative AI tools.

OpenArt

OpenArt Canaan Partners

canaan.comDEC 2025

DEC 2025

Exit

Portfolio company Halda Therapeutics acquired by Johnson & Johnson for $3.05B.

Halda Therapeutics

Halda TherapeuticsCanaan Partners

ventures.yale.eduNOV 17, 2025

NOV 17, 2025